PE20010128A1 - Composicion de un agonista del receptor 5ht1 y un inhibidor de la cox-2 para el tratamiento de la migrana - Google Patents
Composicion de un agonista del receptor 5ht1 y un inhibidor de la cox-2 para el tratamiento de la migranaInfo
- Publication number
- PE20010128A1 PE20010128A1 PE2000000436A PE0004362000A PE20010128A1 PE 20010128 A1 PE20010128 A1 PE 20010128A1 PE 2000000436 A PE2000000436 A PE 2000000436A PE 0004362000 A PE0004362000 A PE 0004362000A PE 20010128 A1 PE20010128 A1 PE 20010128A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- halo
- day
- composition
- migrana
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
Abstract
SE REFIERE A UNA COMPOSICION QUE COMPRENDE a)UN AGONISTA DEL RECEPTOR 5HT1 TAL COMO ELETRIPTAN, RIZATRIPTAN, ZOLMITRIPTAN, SUMATRIPTAN, NARATRIPTAN, UTILIZANDOSE 0,05 mg/DIA A 100 mg/DIA; b)UN COMPUESTO DE FORMULA I, DONDE: R1 ES H, ALQUILO C1-C4; R2 ES C(=L`)R3, SO2R4; Y ES UN ENLACE, ALQUILENO C1-C4; L Y L' SON O, S; Q ES ALQUILO C1-C6, ENTRE OTROS; R3 ES OR6, NR7R8, R(OR1)R7, GRUPO a; Z ES UN ENLACE, O, S, NR5; R4 ES ALQUILO C1-C6, ALQUILO C1-C4 SUSTITUIDO CON HALO, ALQUIL C1-C4-OH, NR7R8, ENTRE OTROS; R5 ES ALQUILO C1-C4 SUSTITUIDO CON HALO; R6 ES ALQUILO C1-C4, CICLOALQUILO C3-C7, ENTRE OTROS; R7 Y R8 SON H, ALQUILO C1-C6, ENTRE OTROS; X ES HALO, ALQUILO C1-C4 OPCIONALMENTE SUSTITUIDO CON HIDROXI, ALCOXI C1-C4, ENTRE OTROS, n ES 0-3 O UN COMPUESTO DE FORMULA XX, DONDE A ES UN ANILLO HETEROCICLO DE 5 MIEMBROS; R1 ES ARILO, HETEROARILO; R2 ES ALQUILO C1-C4; R3, R4 Y R5 SON H, HALO, ALQUILO C1-C4, ENTRE OTROS; R6 Y R7 SON H, HALO, ALQUILO, ENTRE OTROS; m Y n SON 1-4; CUANDO A CONTIENE O, S, UNO DE R3, R4, R5 ESTA AUSENTE; UN INHIBIDOR DE LA CICLOOXIGENASA-2 TAL COMO (2-BENZOIL-6-CLORO-1H-INDOL-3-IL)ACETATO DE ETILO, ACIDO [6-CLORO-2-(2-METILBENZOIL)-1H-INDOL-3-IL]ACETICO, ENTRE OTROS; UTILIZANDOSE 10 mg/DIA A 300mg/DIA. LA COMPOSICION ES UTIL PARA EL TRATAMIENTO DE LA MIGRANA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13431299P | 1999-05-14 | 1999-05-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20010128A1 true PE20010128A1 (es) | 2001-02-28 |
Family
ID=22462780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000000436A PE20010128A1 (es) | 1999-05-14 | 2000-05-10 | Composicion de un agonista del receptor 5ht1 y un inhibidor de la cox-2 para el tratamiento de la migrana |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20050101653A1 (es) |
| EP (1) | EP1051995A3 (es) |
| JP (1) | JP2000344667A (es) |
| KR (1) | KR20010029716A (es) |
| AU (1) | AU3406500A (es) |
| CA (1) | CA2308826A1 (es) |
| CO (1) | CO5261541A1 (es) |
| HU (1) | HUP0001891A3 (es) |
| IL (1) | IL136025A0 (es) |
| PE (1) | PE20010128A1 (es) |
| ZA (1) | ZA200002338B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8022095B2 (en) | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
| DE69922688T2 (de) | 1998-11-02 | 2005-12-01 | Merck & Co. Inc. | Zusammensetzungen aus einem 5ht1b/1d agonisten und einem selektiven cox-2 hemmer zur behandlung von migräne |
| GB9929039D0 (en) * | 1999-12-08 | 2000-02-02 | Glaxo Group Ltd | Medicaments |
| US7332183B2 (en) | 2002-12-26 | 2008-02-19 | Pozen Inc. | Multilayer dosage forms containing NSAIDs and triptans |
| WO2004089365A1 (en) * | 2003-04-11 | 2004-10-21 | Pfizer Limited | Pharmaceutical combination comprising eletriptan and sodium bicarbonate |
| US8618157B2 (en) | 2008-06-20 | 2013-12-31 | Alphapharm Pty. Ltd. | Pharmaceutical formulation |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5545644A (en) * | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
| US5286843A (en) * | 1992-05-22 | 1994-02-15 | Rohm And Haas Company | Process for improving water-whitening resistance of pressure sensitive adhesives |
| US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| ATE233245T1 (de) * | 1993-11-30 | 2003-03-15 | Searle & Co | Substituierte pyrazolyl-benzolsulfonamide und ihre verwendung als cyclooxygenaseii inhibitoren |
| US5466823A (en) * | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
| US5691374A (en) * | 1995-05-18 | 1997-11-25 | Merck Frosst Canada Inc. | Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors |
| US5861419A (en) * | 1996-07-18 | 1999-01-19 | Merck Frosst Canad, Inc. | Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| US5872145A (en) * | 1996-08-16 | 1999-02-16 | Pozen, Inc. | Formulation of 5-HT agonist and NSAID for treatment of migraine |
| US6077850A (en) * | 1997-04-21 | 2000-06-20 | G.D. Searle & Co. | Substituted benzopyran analogs for the treatment of inflammation |
| US6034256A (en) * | 1997-04-21 | 2000-03-07 | G.D. Searle & Co. | Substituted benzopyran derivatives for the treatment of inflammation |
| US5994379A (en) * | 1998-02-13 | 1999-11-30 | Merck Frosst Canada, Inc. | Bisaryl COX-2 inhibiting compounds, compositions and methods of use |
-
2000
- 2000-05-08 IL IL13602500A patent/IL136025A0/xx unknown
- 2000-05-08 CO CO00032908A patent/CO5261541A1/es not_active Application Discontinuation
- 2000-05-10 EP EP00303914A patent/EP1051995A3/en not_active Withdrawn
- 2000-05-10 PE PE2000000436A patent/PE20010128A1/es not_active Application Discontinuation
- 2000-05-12 ZA ZA200002338A patent/ZA200002338B/xx unknown
- 2000-05-12 CA CA002308826A patent/CA2308826A1/en not_active Abandoned
- 2000-05-12 HU HU0001891A patent/HUP0001891A3/hu unknown
- 2000-05-12 AU AU34065/00A patent/AU3406500A/en not_active Abandoned
- 2000-05-13 KR KR1020000025586A patent/KR20010029716A/ko not_active Ceased
- 2000-05-15 JP JP2000141897A patent/JP2000344667A/ja not_active Abandoned
-
2004
- 2004-12-09 US US11/008,765 patent/US20050101653A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CO5261541A1 (es) | 2003-03-31 |
| HUP0001891A3 (en) | 2003-07-28 |
| EP1051995A3 (en) | 2003-01-08 |
| IL136025A0 (en) | 2001-05-20 |
| HU0001891D0 (en) | 2000-07-28 |
| EP1051995A2 (en) | 2000-11-15 |
| HUP0001891A2 (en) | 2001-03-28 |
| CA2308826A1 (en) | 2000-11-14 |
| JP2000344667A (ja) | 2000-12-12 |
| US20050101653A1 (en) | 2005-05-12 |
| AU3406500A (en) | 2000-11-16 |
| ZA200002338B (en) | 2001-11-12 |
| KR20010029716A (ko) | 2001-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20010389A1 (es) | Combinacion de un agonista del receptor 5ht1, cafeina, un inhibidor de la cox-2 y su uso para el tratamiento de la migrana | |
| TW346485B (en) | Substituted N-(indole-2-carbonyl)-glycinamides and derivatives as antidiabetic agents | |
| YU32100A (sh) | Derivati hidrosamske kiseline kao inhibitori matrične metaloproteaze (mmp) | |
| PE108898A1 (es) | Derivados 6,5-heterobiciclicos sustituidos | |
| EA200600348A1 (ru) | Новые соединения | |
| BR9207030A (pt) | Derivados de piperazina como antagonistas de receptores 5-HT | |
| ES2173846T3 (es) | Compuestos de biciclocarbonil indol como agentes antiinflamatorios/analgesicos y como inhibidores de cox-2. | |
| PE20000055A1 (es) | Compuestos de indol 2,3-sustituidos como agentes anti-inflamatorios y analgesicos | |
| ATE168102T1 (de) | 1,4-benzodiazepinderivate und ihre verwendung als cck-modulatoren | |
| ES2178451T3 (es) | Derivados de benzoxadiazoles, benzotiadiazoles, benzotriazoles y quinoxalinas. | |
| FI941644A0 (fi) | Sieniä vastustavat triatsoliyhdisteet | |
| DK1189900T3 (da) | Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler | |
| PE20010128A1 (es) | Composicion de un agonista del receptor 5ht1 y un inhibidor de la cox-2 para el tratamiento de la migrana | |
| NZ513594A (en) | Heterocyclic compounds, intermediates thereof and elastase inhibitors | |
| AR068425A1 (es) | Metodo de alimentacion de cerdos con compuestos de glicina | |
| NZ505060A (en) | 2-Aryl or heterocyclyl substituted indole derivatives useful for the treatment of osteoporosis | |
| PE20060074A1 (es) | Derivados de (indol-3-il)-heterociclos | |
| ATE18221T1 (de) | (1-arylcyclobutyl)(heterocyclyl)methylaminderivate, ihre herstellung und ihre verwendung als arzneimittel. | |
| DK0707570T3 (da) | Isoquinolinderivater som terapeutiske midler | |
| ES2128572T3 (es) | Utilizacion de los derivados de cefem como agentes antimetastaticos. | |
| PE20010513A1 (es) | Combinacion de un agonista del receptor 5ht1, cafeina, un inhibidor de la cox-2 | |
| ATE172724T1 (de) | Anthelmintische benzimidazole | |
| PE20010134A1 (es) | Uso de agonistas de receptores 5ht1 y un inhibidor de la cox-2 para el tratamiento de la migrana | |
| AP2001002314A0 (en) | Substituted benzolactam compounds. | |
| HU9503718D0 (en) | Serotoninergic abeo-ergoline derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |